Skip to main content
Clinical Trials/NCT02036892
NCT02036892
Unknown
Phase 3

Electronically Connected Health Coaching in Improving Type 2 Diabetes Self Management - Phase III Trial

York University1 site in 1 country115 target enrollmentFebruary 2012
ConditionsType 2 Diabetes

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
York University
Enrollment
115
Locations
1
Primary Endpoint
Hemoglobin A1c
Last Updated
12 years ago

Overview

Brief Summary

Patients with Type 2 Diabetes randomly allocated to the intervention arm (health coaching + smartphone-based health promotion software) will have significantly better Hemoglobin A1c levels at 6 months post-intervention than patients with Type 2 Diabetes allocated to the control arm (health coaching alone).

Detailed Description

Inclusion criteria: all participating patients have been diagnosed with Type 2 Diabetes, are between 25 and 70 years of age, have a regular primary care physician, and have HbA1c levels \> or = to 7.3. Exclusion criteria: Axis I and II psychiatric disorders. Primary outcome: HBA1c at 6 months follow up. Secondary outcome: Centre for Epidemiological Studies Depression Scale

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
June 2014
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Paul Ritvo

Associate Professor, School of Kinesiology and Health Science

York University

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Type 2 Diabetes
  • Fluency in English and/or Spanish

Exclusion Criteria

  • \> 75 years of age

Outcomes

Primary Outcomes

Hemoglobin A1c

Time Frame: 6 months follow up from baseline

Finger prick A1c test or lab test

Secondary Outcomes

  • Center for Epidemiological Studies Depression Scale(6 months follow up from baseline assessment)

Study Sites (1)

Loading locations...

Similar Trials